Načítá se...
Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
Genetic variations in individuals may cause differences in the response to cholinesterase inhibitor drugs used in the treatment of Alzheimer’s disease (AD). Through this review, we aimed to understand the potential relationship between genetic polymorphisms and treatment response in AD. We conducted...
Uloženo v:
| Vydáno v: | Clin Interv Aging |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445219/ https://ncbi.nlm.nih.gov/pubmed/30992661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S200109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|